Author:
Campbell Steven C.,Flanigan Robert C.,Clark Joseph I.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference26 articles.
1. Flanigan RC, Yonover PM, Campbell SC: Role of nephrectomy in metastatic renal cell carcinoma. Am Urol Assoc Update Ser 2002, 21:242–247. A comprehensive review of the role of surgery in the management of patients with metastatic RCC.
2. Gottesman JE, Crawford ED, Grossman HS, et al.: Infarction: nephrectomy for metastatic renal cell carcinoma. Urology 1985, 25:248.
3. Figlin RA, Thompson JA, Bukowski RM, et al.: Multicenter, randomized, phase III trial of CD8+ tumorinfiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol 1999, 17:2521–2529.
4. Kavolius DP, Mastorakos C, Pavlovich P, et al.: Resection of metastatic renal cell carcinoma. J Clin Oncol 1998, 16:2261–2266. One of the largest series reporting outcomes for metastasectomy for patients with RCC.
5. Flanigan RC, Salmon SE, Blumenstein BA, et al.: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal cell cancer. N Engl J Med 2001, 345:1655–1659. A randomized prospective trial evaluating the role of cytoreductive nephrectomy for patients with metastatic RCC.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献